Semax 10mg

Exploring Semax Peptide Research and Mechanisms

Semax peptide is a synthetic heptapeptide developed for laboratory investigation. Researchers examine this compound in preclinical models to understand its effects on neurotrophic pathways. This article reviews current data on its molecular structure, cellular mechanisms, and ongoing in vitro studies.

What is Semax Peptide?

Semax is an analogue derived from a fragment of adrenocorticotropic hormone (ACTH). Laboratory investigation focuses on its stabilized Pro-Gly-Pro tail, which researchers hypothesize alters enzymatic breakdown.

Molecular Structure and Properties

In vitro studies measure the water-soluble properties of this peptide. Preclinical models evaluate how the sequence Met-Glu-His-Phe-Pro-Gly-Pro interacts with the central nervous system (CNS).
Researchers examine:

• Molecular weight of approximately 813.9 g/mol

• Structural stability against enzymatic degradation

• Central nervous system penetration characteristics

Mechanisms of Action

Animal studies explore several potential pathways when evaluating this compound. Current research investigates specific cellular responses without the hormonal effects of full ACTH.

Neurotrophic and Receptor Pathways

Laboratory investigation examines how the peptide influences brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) (PubMed). These proteins are critical for neuroplasticity (the brain’s ability to form new connections).
Studies investigate:

• BDNF and NGF expression in the hippocampus

• Monoamine regulation (serotonin and dopamine pathways)

• Cholinergic activity related to memory models

Cellular Protection Models

Preclinical models measure responses to oxidative stress (cellular damage from free radicals). Research examines the upregulation of antioxidant enzymes in subject models.

Preclinical Investigation Areas

Researchers investigate this peptide in various injury and stress models. Animal studies examine recovery markers following ischemic events (reduced blood flow).
Observations in these models include:

• Modulation of the hypothalamic-pituitary-adrenal (HPA) axis

• Measured decreases in pro-inflammatory cytokine production

• Neuronal survival rates in experimental injury models

Comparing Semax to Other Research Peptides

Researchers often compare structural variations among different synthetic compounds to understand binding affinities.

Frequently Asked Questions (FAQ)

What is Semax peptide investigated for?

Research examines its role in neurotrophic signaling and cellular protection pathways. Animal studies measure its interaction with BDNF and neurotransmitter turnover in specific brain regions.

How is the peptide structured?

The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, derived from ACTH residues 4-10. The added Pro-Gly-Pro tail is studied for its resistance to enzymatic breakdown during laboratory investigation.

Conclusion on Semax Peptide Research

In conclusion, Semax peptide remains a significant subject of laboratory investigation regarding neuroplasticity and cellular protection. Preclinical models continue to explore its mechanisms within neurotransmitter systems. Human evidence is absent or limited, and further in vitro studies are required to understand its complete pharmacological profile. View our selection of compounds at our research peptides in our shop.

References

1. Ashmarin, I. P., et al. Neuroscience Research Communications. PubMed

2. Kaplan, A. Y., et al. Neuroscience Letters. PubMed

3. Dolgov, O. N., et al. Bulletin of Experimental Biology and Medicine. PubMed

4. Levitskaya, N. G., et al. Neuroscience and Behavioral Physiology. PubMed

5. Shadrina, M. I., et al. Molecular Biology. PubMed